期刊
TISSUE ENGINEERING PART A
卷 16, 期 6, 页码 1801-1809出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/ten.tea.2009.0539
关键词
-
资金
- National Institutes of Health [K01AR052352-01A1, R01AR0-56445-01A2, R01DE019935-01]
- Whitaker Foundation
- National Institute of Dental & Craniofacial Research [DE-010369-08]
- Biotechnology Training Program [T32 GM-008715-03]
- National Science Foundation
- American Heart Association-Mid-Atlantic Affiliate
The calvarial bone microenvironment contains a unique progenitor niche that should be considered for therapeutic manipulation when designing regeneration strategies. Recently, our group demonstrated that cells isolated from the dura are multipotent and exhibit expansion potential and robust mineralization on biodegradable constructs in vitro. In this study, we evaluate the effectiveness of healing critical-sized cranial bone defects by enhancing microvascular network growth and host dura progenitor trafficking to the defect space pharmacologically by delivering drugs targeted to sphingosine 1-phosphate (S1P) receptors. We demonstrate that delivery of pharmacological agonists to (S1P) receptors S1P(1) and S1P(3) significantly increase bone ingrowth, total microvessel density, and smooth muscle cell investment on nascent microvessels within the defect space. Further, in vitro proliferation and migration studies suggest that selective activation of S1P(3) promotes recruitment and growth of osteoblastic progenitors from the meningeal dura mater.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据